Skip to content

Live Events

Live Events

Live Events

Live Events

MEC Basic Full List View

By pinki@katapult.biz / February 16, 2025

MEC Basic

Events

Speciality

Type of Media

Author / Speaker

Title

Search Entries:

«
1
…
50
51
52
53
54
…
66
»

Chimeric Antigen Receptor T-cell therapy in 2020: Current Indications

Chimeric Antigen Receptor T-cell therapy in 2020: Current Indications

Mohamed A. Kharfan-Dabaja, MD, MBA, FACP

De Novo Acute Myeloid Leukemia

De Novo Acute Myeloid Leukemia

Rami Komrokji, MD

Anticoagulation in Oncology: What’s New?

Anticoagulation in Oncology: What’s New?

Craig S. Kitchens, MD, MACP

Palliative Care and the Importance of Advanced Care Planning

Palliative Care and the Importance of Advanced Care Planning

Sarah Lowry, DNP, ACNP-BC, AOCNP, ACHPH

Integration of Biosimilars in Oncology Care

Integration of Biosimilars in Oncology Care

Jorge J. Garcia, PharmD, MS, MHA, MBA, FACHE

Natural Disasters: Infamy vs. Nature – What Lessons Can We Learn

Natural Disasters: Infamy vs. Nature – What Lessons Can We Learn

Antonia Coello Novello, MD, MPH, DR.PH

Small Cell and Neuroendocrine Carcinoma of The Lung

Small Cell and Neuroendocrine Carcinoma of The Lung

Janakiraman Subramanian, MD, MPH

RET, MET, NTRK

Luis E. Raez, MD

EGFR: Common and Uncommon Mutations - What Is Next for These Patient Populations?

EGFR: Common and Uncommon Mutations - What Is Next for These Patient Populations?

Joshua Bauml, MD

ALK Mutant NSCLC: What’s New and Do We Have a Sequencing?

ALK Mutant NSCLC: What’s New and Do We Have a Sequencing?

Rita S. Axelrod, MD

Breast Cancer Case: Part 2

Breast Cancer Case: Part 2

Mohammad Jahanzeb, MD

Breast Cancer Case: Part 1

Breast Cancer Case: Part 1

Mohammad Jahanzeb, MD

Novel Targeted Therapeutic Approaches for Breast Cancer

Novel Targeted Therapeutic Approaches for Breast Cancer

Mark Pegram, MD

New Directions in Adjuvant Endocrine Therapy

New Directions in Adjuvant Endocrine Therapy

Marianna Chavez-MacGregor, MD

Targeted Therapy for Metastatic HR+/HER2- Breast Cancer: CDK4/6 and PI3K

Targeted Therapy for Metastatic HR+/HER2- Breast Cancer: CDK4/6 and PI3K

Hope S. Rugo, MD

Immunotherapy in Breast Cancer: Recent Updates

Immunotherapy in Breast Cancer: Recent Updates

Edith A. Pérez, MD

Emerging Biomarkers for Immunotherapy in NSCLC

Emerging Biomarkers for Immunotherapy in NSCLC

David R. Gandara, MD

HRPC: How to Sequence Multiple Therapies

HRPC: How to Sequence Multiple Therapies

Daniel P. Petrylak, MD

Immunotherapy and Other Systemic Therapy in Gynecologic Malignancies

Immunotherapy and Other Systemic Therapy in Gynecologic Malignancies

Gerardo Colon-Otero, MD

Common Misunderstandings in IO

Common Misunderstandings in IO

Laura J. Zitella, MS, RN, ACNP-BC, AOCN

Immunotherapy and Targeted Therapy in Melanoma

Immunotherapy and Targeted Therapy in Melanoma

Sanjiv S. Agarwala, MD

Immunotherapy in Kidney & Bladder Cancers

Immunotherapy in Kidney & Bladder Cancers

David I. Quinn, MBBS, PhD, FRACP, FACP

Immunotherapy in Lung Cancer

Immunotherapy in Lung Cancer

Hossein Borghaei, DO, MS

Impact of COVID-19 on Cancer Care

Impact of COVID-19 on Cancer Care

Jessica MacIntyre, MSN, APRN, NP-C, AOCNP

Integrating Biomarkers and Targeted Therapy into Colorectal Management

Integrating Biomarkers and Targeted Therapy into Colorectal Management

Mitesh J. Borad, MD

Gastric and Esophageal Cancers

Gastric and Esophageal Cancers

Thomas Reske, MD, PhD, FACP, CMD

Pancreatic and Biliary Cancers: Moving the Bar Up?

Pancreatic and Biliary Cancers: Moving the Bar Up?

Caio Max S. Rocha Lima, MD, MS

Colon Cancer: Where Are We?

Colon Cancer: Where Are We?

Axel Grothey, MD

Radiotherapy & Immunotherapy Applications in Oncology

Radiotherapy & Immunotherapy Applications in Oncology

Puneeth Iyengar, MD, PhD

Emerging Combination in Sarcoma Immunotherapy

Emerging Combination in Sarcoma Immunotherapy

Pasquale W. Benedetto, MD

Displaying 1,531 - 1,560 of 1,953

«
1
…
50
51
52
53
54
…
66
»

← Previous View

6619 South Dixie Highway #341
Miami, FL 33143

Phone: 305.663.1628
Email: info@meccinc.com

Userful Links

Live Events

Categories

About Us

Why Subscribe
About Us
Accreditation

© 2025 MEC Inc. All rights reserved | Digital Marketing by Katapult Marketing

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok